


Healthcare News Roundup: Generic Pharmaceuticals
HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
HSMN NewsFeed - 18 Jul 2006
Ranbaxy to Acquire the Mundogen Generic Business of GlaxoSmithKline in Spain
Ranbaxy to Acquire the Mundogen Generic Business of GlaxoSmithKline in Spain
HSMN NewsFeed - 18 Jul 2006
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
HSMN NewsFeed - 17 Jul 2006
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
HSMN NewsFeed - 13 Jul 2006
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
HSMN NewsFeed - 12 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R)
HSMN NewsFeed - 30 Jun 2006
Par Pharmaceutical Receives Final Approval to Market Tranylcypromine Sulfate Tablets
Par Pharmaceutical Receives Final Approval to Market Tranylcypromine Sulfate Tablets
HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
HSMN NewsFeed - 23 Jun 2006
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
